Literature DB >> 7158775

Preparation of three types of heparin-sepharose and their binding activities to thrombin and antithrombin III.

M Funahashi, I Matsumoto, N Seno.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1982        PMID： 7158775     DOI： 10.1016/0003-2697(82)90537-1

Source DB:  PubMed          Journal:  Anal Biochem        ISSN： 0003-2697            Impact factor:   3.365


× No keyword cloud information.
  6 in total

1.  Mechanism of inhibition of mammalian DNA topoisomerase I by heparin.

Authors:  K Ishii; S Futaki; H Uchiyama; K Nagasawa; T Andoh
Journal:  Biochem J       Date:  1987-01-01       Impact factor: 3.857

2.  Heparin- and sulfatide-binding peptides from the type I repeats of human thrombospondin promote melanoma cell adhesion.

Authors:  N H Guo; H C Krutzsch; E Nègre; T Vogel; D A Blake; D D Roberts
Journal:  Proc Natl Acad Sci U S A       Date:  1992-04-01       Impact factor: 11.205

3.  Subcellular co-localization and potential interaction of glucuronosyltransferases with nascent proteochondroitin sulphate at Golgi sites of chondroitin synthesis.

Authors:  G Sugumaran; M Katsman; J E Silbert
Journal:  Biochem J       Date:  1998-01-01       Impact factor: 3.857

4.  Aggregation-independent modulation of proteoglycan binding by neutralization of C-terminal acidic residues in the chemokine macrophage inflammatory protein 1alpha.

Authors:  K Ottersbach; G J Graham
Journal:  Biochem J       Date:  2001-03-01       Impact factor: 3.857

5.  Receptor for advanced glycation end products (RAGE) functions as receptor for specific sulfated glycosaminoglycans, and anti-RAGE antibody or sulfated glycosaminoglycans delivered in vivo inhibit pulmonary metastasis of tumor cells.

Authors:  Shuji Mizumoto; Jun Takahashi; Kazuyuki Sugahara
Journal:  J Biol Chem       Date:  2012-04-09       Impact factor: 5.157

6.  Structure of a heparan sulphate oligosaccharide that binds to basic fibroblast growth factor.

Authors:  H Habuchi; S Suzuki; T Saito; T Tamura; T Harada; K Yoshida; K Kimata
Journal:  Biochem J       Date:  1992-08-01       Impact factor: 3.857
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.